Viatris, Inc. (VTRS)
16.20
+0.26
(+1.66%)
USD |
NASDAQ |
Jun 09, 16:00
16.20
0.00 (0.00%)
After-Hours: 18:03
Viatris SG&A Expense (Quarterly) : 928.80M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.961B |
| Bristol Myers Squibb Co. | 1.617B |
| Eli Lilly & Co. | 2.934B |
| Teva Pharmaceutical Industries Ltd. | 997.29M |
| Merck & Co., Inc. | 2.70B |